Scarica l'app Stockscreener
12.68
1.86%
-0.24
Precedente Chiudi:
$12.92
Aprire:
$13
Volume 24 ore:
29,643
Relative Volume:
1.04
Capitalizzazione di mercato:
$25.95M
Reddito:
-
Utile/perdita netta:
$-4.85M
Rapporto P/E:
-40.90
EPS:
-0.31
Flusso di cassa netto:
$-3.95M
1 W Prestazione:
+13.72%
1M Prestazione:
+3.43%
6M Prestazione:
-33.54%
1 anno Prestazione:
+67.72%
Intervallo 1D:
$12.07
$13.00
Intervallo di 1 settimana:
$10.28
$13.00
Portata 52W:
$5.70
$22.90
Cadrenal Therapeutics Inc Stock (CVKD) Company Profile
Nome
Cadrenal Therapeutics Inc
Settore
Industria
Telefono
904-300-0701
Indirizzo
822 A1A NORTH, PONTE VEDRA
Confronta CVKD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CVKD
Cadrenal Therapeutics Inc
|
12.68 | 26.45M | 0 | -4.85M | -3.95M | -0.31 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.79 | 100.07B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.41 | 59.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.91 | 58.03B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
653.83 | 39.93B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
321.36 | 36.82B | 3.81B | -644.79M | -669.77M | -6.24 |
Cadrenal Therapeutics Inc Stock (CVKD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-12-18 | Iniziato | Noble Capital Markets | Outperform |
Cadrenal Therapeutics Inc Borsa (CVKD) Ultime notizie
Combining price and volume data for Cadrenal Therapeutics Inc.2025 Analyst Calls & Real-Time Chart Breakout Alerts - Newser
Earnings visualization tools for Cadrenal Therapeutics Inc.2025 Earnings Impact & Weekly High Potential Stock Alerts - Newser
Trend analysis for Cadrenal Therapeutics Inc. this week2025 Dividend Review & Consistent Return Strategy Ideas - Newser
Can machine learning forecast Cadrenal Therapeutics Inc. recoveryQuarterly Portfolio Report & Trade Opportunity Analysis - Newser
Custom strategy builders for tracking Cadrenal Therapeutics Inc.July 2025 Market Mood & Low Drawdown Momentum Ideas - Newser
Real time breakdown of Cadrenal Therapeutics Inc. stock performanceGap Down & Weekly Setup with High ROI Potential - Newser
Using data tools to time your Cadrenal Therapeutics Inc. exitJuly 2025 Technicals & Long-Term Safe Investment Ideas - Newser
Best data tools to analyze Cadrenal Therapeutics Inc. stockPortfolio Risk Report & Reliable Entry Point Trade Alerts - Newser
Is Cadrenal Therapeutics Inc. stock a good pick for beginnersPortfolio Growth Summary & Free Accurate Trade Setup Notifications - newsyoung.net
Q3 EPS Estimate for Cadrenal Therapeutics Lifted by Analyst - Defense World
How TOYO stock performs during market volatility2025 Fundamental Recap & Verified Momentum Stock Alerts - thegnnews.com
Is It Too Late to Sell Cadrenal Therapeutics Inc.Stock Surge & Weekly High Return Stock Forecasts - classian.co.kr
Cadrenal Therapeutics Advances Tecarfarin Development - TipRanks
Q1 Earnings Forecast for CVKD Issued By Noble Financial - Defense World
Using economic indicators to assess Cadrenal Therapeutics Inc. potential2025 Short Interest & Advanced Swing Trade Entry Plans - Newser
Signal strength of CLSD stock in tech scannersFree Pattern Breakout Entry Stock Forecast - Newser
Will LILAK face regulatory challengesHigh ROE Investment Ideas - sisain.net
Tools to monitor Cadrenal Therapeutics Inc. recovery probabilityFast Movement Forecast for Trading Success - Newser
Cadrenal Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update - BioSpace
How to forecast ABIG trends using time seriesFree Low Volatility Stable Growth Picks - Newser
Visual analytics tools that track Cadrenal Therapeutics Inc. performanceWeekly Market Direction and Sector Summary - Newser
CVKD Files 8-K; Exhibit 99.1 Contains Q2 2025 Financials - Stock Titan
Cadrenal Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Order flow analysis tools used on Cadrenal Therapeutics Inc.Daily Trade Setup Forecast with Confidence - Newser
Analyzing net buyer seller activity in Cadrenal Therapeutics Inc.Free AI-Powered Trade Planning with Indicators - Newser
TZUP Stock Chart Analysis: Bullish or Bearish Pattern FormingTrade Plan With Low Risk High Return - Newser
Is ECDA a Top Dividend Stock to Watch in 2025Pattern Breakout Tracker with Screener Tools - Newser
Main Inc. stock performs during market volatilityDaily Technical Forecast for Quick Gains - Newser
Cadrenal Therapeutics Inc. stock outlook for YEARChart Driven Entry Timing for Swing Trades - Newser
How volatile is SBXD.WS stock10-Bagger Stock Radar - mustnews.co.kr
How Cadrenal Therapeutics Inc. stock performs during market volatilityInvestment Timeline and ROI Summary Report - Newser
Real time pattern detection on CVLT stockExit Strategy Guide With Risk Control Plan - Newser
Can CDIOW hit a new high this monthTechnical Setup Guide for Daily Watchlist - Newser
How to interpret RSI for GCT Semiconductor Holding Inc. stockSummary of Trade Cycles in 5-Year Range - Newser
Is RITM.PRD a candidate for recovery playWeekly Breakout Forecast with Entry Zones - Newser
New Product Launches: Will They Boost TuHURA Biosciences Inc. Stock in 2025Weekly Trend Screener with Momentum Picks - Newser
Cadrenal Therapeutics shares rise 2.36% intraday after Crinetics Pharmaceuticals reported progress on PALSONIFY™ and Atumelnant development. - AInvest
Can you recover from losses in Exicure Inc.3-Year Equity Summary With Setup Insights - Newser
Using data models to predict Cadrenal Therapeutics Inc. stock movementTrade Flow Monitor with Volume Tracker - Newser
Long term hold vs stop loss in Cadrenal Therapeutics Inc.Multi-Year Investment Performance Summary Report - Newser
Will Nordic American Tankers Limited stock go up soonShort-Term Sector Movement Forecast Generator - Newser
What to do if you’re stuck in Nvni Group Limited Equity WarrantWeekly Setup Summary for Risk Controlled Trades - Newser
Cadrenal Therapeutics Inc Azioni (CVKD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.41%
0.88%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):